Radium-223 dichloride (xofigo)
Ended Awarded
- Contract number
- 36C25022N0075
- Awardee
-
Bayer Healthcare Pharmaceuticals Inc. UEI V1EVGCK7XES8
- Awarding agency
-
Veterans Integrated Service Network 10
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $272,865
Award facts
- Contract value 100% obligated
- $272,864.85 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Dublin, OH 43017, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10 awarded a $272,864.85 firm fixed price blanket purchase agreement call contract to Bayer Healthcare Pharmaceuticals Inc. for the pharmaceutical radium-223 dichloride, marketed as Xofigo, with a period of performance through September 30, 2024. The contract was awarded off the Pharmaceuticals and Drugs multiple award schedule (FSS-61-IB) managed by the General Services Administration. No set-aside designation was used for this award to Bayer Healthcare Pharmaceuticals Inc., which will supply the radiopharmaceutical from its location in Dublin, Ohio in support of cancer treatment services provided by VISN 10 to veterans within its region.
Quick answers
Who was awarded contract 36C25022N0075?
36C25022N0075 was awarded to Bayer Healthcare Pharmaceuticals Inc. by Veterans Integrated Service Network 10 (Veterans Health Administration) on October 1, 2021.
How much is contract 36C25022N0075 worth?
The government has obligated $272,865 on 36C25022N0075.
Is contract 36C25022N0075 an order under another contract?
Yes. 36C25022N0075 is a BPA call under V797P2202D-36C25020A0024, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C25022N0075 competed?
The extent of competition for 36C25022N0075 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award